Letermovir
CAS 917389-32-3
Em Estoque
Letermovir
Cat. No. ANT-LTM-000CAS 917389-32-3Em Estoque
Dados Técnicos
Cat. No.ANT-LTM-000
CAS917389-32-3
Fórmula Mol.C29H28F4N4O4
Peso Mol.572.6 g/mol
IUPAC2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid
SMILESCOC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O
InChIInChI=1S/C29H28F4N4O4/c1-40-20-6-3-5-19(16-20)35-11-13-36(14-12-35)28-34-27-21(7-4-8-22(27)30)23(17-26(38)39)37(28)24-15-18(29(31,32)33)9-10-25(24)41-2/h3-10,15-16,23H,11-14,17H2,1-2H3,(H,38,39)/t23-/m0/s1
Chave InChIFWYSMLBETOMXAG-QHCPKHFHSA-N
Pureza99%
Descrição
Visão geral
Letermovir is an antiviral medication used for prophylaxis in adult transplant recipients at risk of cytomegalovirus (CMV) infection and disease
A Anant Labs fabrica e fornece impurezas de Letermovir de alta qualidade para o mercado global. Nossas impurezas EP de Letermovir são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
(S)-2-(8-Fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acidLetermovir917389-32-3PrevymisAIC246AIC-246MK-8228AIC 2461H09Y5WO1F2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid
